Patents by Inventor Laura S. Stone

Laura S. Stone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Materials For Modulating p2x2
    Publication number: 20080119423
    Abstract: The invention relates to antisense oligonucleotides, compositions and methods useful for modulating the expression of P2X2. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding P2X2.
    Type: Application
    Filed: December 31, 2002
    Publication date: May 22, 2008
    Inventors: Samuel J. Shuster, Ulf N.G. Arvidsson, Laura S. Stone, Hong-Yan Zhang, Lucy Vulchanova Hart
  • Methods and Materials for Modulating Enac-Beta
    Publication number: 20080027015
    Abstract: The invention relates to antisense oligonucleotides, compositions and methods useful for modulating the expression of ENaC-beta. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding ENaC-beta.
    Type: Application
    Filed: December 31, 2002
    Publication date: January 31, 2008
    Inventors: Samuel J. Shuster, Ulf N.G. Arvidsson, Laura S. Stone, Hong-Yan Zhang, Lucy Vulchanova Hart
  • Analgesic composition and method for using same
    Patent number: 6204271
    Abstract: A pharmaceutical analgesic composition comprise an opioid analgesic agent and moxonidine as a non-opioid agent with analgesic activity. Administration of an opioid analgesic agent and moxonidine as a non-opioid agent produces analgesia in the treatment of pain in mammals.
    Type: Grant
    Filed: September 14, 1998
    Date of Patent: March 20, 2001
    Assignee: Solvay Pharmaceuticals GmbH
    Inventors: Carolyn A. Fairbanks, George L. Wilcox, Laura S. Stone, Kelley F. Kitto
  • Methods of using moxonidine to inhibit nociceptive pain
    Patent number: 6117879
    Abstract: Moxonidine and its physiologically compatible acid-addition salts are used for the treatment and/or prophylaxis of nociceptive pain, and in particular nociceptive acute and chronic pain.
    Type: Grant
    Filed: September 14, 1998
    Date of Patent: September 12, 2000
    Assignee: Solvay Pharmaceuticals GmbH
    Inventors: Carolyn A. Fairbanks, George L. Wilcox, Laura S. Stone, Kelley F. Kitto